Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort study

Conclusion
Starting shorter-acting GLP-1 RAs is associated with increased risks of GERD and its complications.

Source: Gut - January 5, 2024 Category: Gastroenterology Authors: Liu, B. D., Udemba, S. C., Liang, K., Tarabichi, Y., Hill, H., Fass, R., Song, G. Tags: Gut Oesophagus Source Type: research